Literature DB >> 20946871

A role for tumor protein TPD52 phosphorylation in endo-membrane trafficking during cytokinesis.

Diana D H Thomas1, Christina L Frey, Scott W Messenger, Benjamin K August, Guy E Groblewski.   

Abstract

Tumor protein D52 is expressed at high levels in exocrine cells containing large secretory granules where it regulates Ca(2+)-dependent protein secretion; however, D52 expression is also highly induced in multiple cancers. The present study investigated a role for the Ca(2+)-dependent phosphorylation of D52 at the single major phospho-acceptor site serine 136 on cell division. Ectopic expression of wild type D52 (D52wt) and the phosphomutants serine 136/alanine (S136A) or serine 136/glutamate (S136/E) resulted in significant multinucleation of cells. D52wt and S136/E each resulted in a greater than 2-fold increase in multinucleated cells compared to plasmid-transfected controls whereas the S136/A phospho-null mutant caused a 9-fold increase in multinucleation at 48h post-transfection. Electron microscopy revealed D52 expression induced a marked accumulation of vesicles along the mid-line between nuclei where the final stages of cell abscission normally occurs. Supporting this, D52wt strongly colocalized on vesicular structures containing the endosomal regulatory protein vesicle associated membrane protein 8 (VAMP 8) and this colocalization significantly increased with elevations in cellular Ca(2+). As VAMP 8 is known to be necessary for the endo-membrane fusion reactions that mediate the final stages of cytokinesis, these data indicate that D52 expression and phosphorylation at serine 136 play an important role in supporting the Ca(2+)-dependent membrane trafficking events necessary for cytokinesis in rapidly proliferating cancer cells.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20946871      PMCID: PMC3026285          DOI: 10.1016/j.bbrc.2010.10.041

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

1.  Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer.

Authors:  Daniel R Rhodes; Terrence R Barrette; Mark A Rubin; Debashis Ghosh; Arul M Chinnaiyan
Journal:  Cancer Res       Date:  2002-08-01       Impact factor: 12.701

2.  Proteomic analysis of human prostate cancer.

Authors:  Mamoun Ahram; Carolyn J M Best; Michael J Flaig; John W Gillespie; Isabel M Leiva; Rodrigo F Chuaqui; Ge Zhou; Hungjun Shu; Paul H Duray; W Marston Linehan; Mark Raffeld; David K Ornstein; Yingming Zhao; Emanuel F Petricoin; Michael R Emmert-Buck
Journal:  Mol Carcinog       Date:  2002-01       Impact factor: 4.784

3.  Identification of Src transformation fingerprint in human colon cancer.

Authors:  Renae L Malek; Rosalyn B Irby; Qingbin M Guo; Kerry Lee; Sylvia Wong; Mei He; Jennifer Tsai; Bryan Frank; Edison T Liu; John Quackenbush; Richard Jove; Timothy J Yeatman; Norman H Lee
Journal:  Oncogene       Date:  2002-10-17       Impact factor: 9.867

4.  Identification of MAL2, a novel member of the mal proteolipid family, though interactions with TPD52-like proteins in the yeast two-hybrid system.

Authors:  S H Wilson; A M Bailey; C R Nourse; M G Mattei; J A Byrne
Journal:  Genomics       Date:  2001-08       Impact factor: 5.736

5.  The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma.

Authors:  R L Balleine; M S Fejzo; P Sathasivam; P Basset; C L Clarke; J A Byrne
Journal:  Genes Chromosomes Cancer       Date:  2000-09       Impact factor: 5.006

6.  CRHSP-28 regulates Ca(2+)-stimulated secretion in permeabilized acinar cells.

Authors:  D D Thomas; W B Taft; K M Kaspar; G E Groblewski
Journal:  J Biol Chem       Date:  2001-05-30       Impact factor: 5.157

7.  Identification of annexin VI as a Ca2+-sensitive CRHSP-28-binding protein in pancreatic acinar cells.

Authors:  Diana D H Thomas; Kala M Kaspar; William B Taft; Ning Weng; Lance A Rodenkirch; Guy E Groblewski
Journal:  J Biol Chem       Date:  2002-07-08       Impact factor: 5.157

8.  Nonredundant functions for tumor protein D52-like proteins support specific targeting of TPD52.

Authors:  Mona Shehata; Ivan Bièche; Rose Boutros; Judith Weidenhofer; Susan Fanayan; Lisa Spalding; Nikolajs Zeps; Karen Byth; Robert K Bright; Rosette Lidereau; Jennifer A Byrne
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

9.  Calcium/calmodulin-dependent phosphorylation of tumor protein D52 on serine residue 136 may be mediated by CAMK2delta6.

Authors:  Catherine S Chew; Xunsheng Chen; Hanfang Zhang; Eric A Berg; Han Zhang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-10-02       Impact factor: 4.052

10.  Tumor protein D52 expression and Ca2+-dependent phosphorylation modulates lysosomal membrane protein trafficking to the plasma membrane.

Authors:  Diana D H Thomas; Christina L Martin; Ning Weng; Jennifer A Byrne; Guy E Groblewski
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-23       Impact factor: 4.249

View more
  8 in total

1.  Tumor protein D52 controls trafficking of an apical endolysosomal secretory pathway in pancreatic acinar cells.

Authors:  Scott W Messenger; Diana D H Thomas; Michelle A Falkowski; Jennifer A Byrne; Fred S Gorelick; Guy E Groblewski
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-07-18       Impact factor: 4.052

2.  Novel Host Proteins and Signaling Pathways in Enteropathogenic E. coli Pathogenesis Identified by Global Phosphoproteome Analysis.

Authors:  Roland Scholz; Koshi Imami; Nichollas E Scott; William S Trimble; Leonard J Foster; B Brett Finlay
Journal:  Mol Cell Proteomics       Date:  2015-05-05       Impact factor: 5.911

3.  Gene set enrichment analysis of the NF-κB/Snail/YY1/RKIP circuitry in multiple myeloma.

Authors:  Apostolos Zaravinos; Peggy Kanellou; George I Lambrou; Demetrios A Spandidos
Journal:  Tumour Biol       Date:  2014-01-31

4.  FIP3-endosome-dependent formation of the secondary ingression mediates ESCRT-III recruitment during cytokinesis.

Authors:  John A Schiel; Glenn C Simon; Chelsey Zaharris; Julie Weisz; David Castle; Christine C Wu; Rytis Prekeris
Journal:  Nat Cell Biol       Date:  2012-09-23       Impact factor: 28.824

5.  Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells.

Authors:  Tom Moritz; Simone Venz; Heike Junker; Sarah Kreuz; Reinhard Walther; Uwe Zimmermann
Journal:  Tumour Biol       Date:  2016-02-05

6.  Increased expression of tumor protein D54 is associated with clinical progression and poor prognosis in patients with prostate cancer.

Authors:  Ligang Ren; Jing Chen; Xinnan Zhang
Journal:  Oncol Lett       Date:  2017-10-18       Impact factor: 2.967

7.  Tumor Protein D52 (TPD52) Inhibits Growth and Metastasis in Renal Cell Carcinoma Cells Through the PI3K/Akt Signaling Pathway.

Authors:  Zhenhua Zhao; Hui Liu; Junqing Hou; Tieqiang Li; Xinyi Du; Xiaolei Zhao; Wenchao Xu; Weibo Xu; Junkai Chang
Journal:  Oncol Res       Date:  2016-11-08       Impact factor: 5.574

8.  Intracellular nanovesicles mediate α5β1 integrin trafficking during cell migration.

Authors:  Gabrielle Larocque; Daniel J Moore; Méghane Sittewelle; Cansu Kuey; Joseph H R Hetmanski; Penelope J La-Borde; Beverley J Wilson; Nicholas I Clarke; Patrick T Caswell; Stephen J Royle
Journal:  J Cell Biol       Date:  2021-07-21       Impact factor: 8.077

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.